Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma

NCT01522872 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: TH-302
DRUG: TH-302 and Dexamethasone
DRUG: TH-302 Dose Escalation and Dexamethasone in Combination with Bortezomib
DRUG: TH-302 Dose Escalation and Dexamethasone in Combination with Pomalidomide

Sponsor

Threshold Pharmaceuticals